Cannabis Law Report

NOVEMBER 24, 2019

Chronic pain. Severe treatment-resistant epilepsy. Chronic pain. Do not offer the following to manage chronic pain in adults: nabilone. THC ( delta-9-tetrahydrocannabinol). a combination of cannabidiol (CBD) with THC. THC ( delta-9-tetrahydrocannabinol). Rationale and impact.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Healer

FEBRUARY 11, 2022

People are even more surprised to learn that the cannabis plant does not directly produce THC (delta-9-tetrahydrocannabinol), but instead produces an acidic precursor called THCA (tetrahydrocannabinolic acid ) with distinct but important health benefits. Still, most cannabis users don’t recognize the value of this acidic form of THC.

Tincture 52

Tincture THC Epilepsy Cannabinoids 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Cancer pain. Neuropathic pain. Conclusions. 2016 ; Sznitman et al. years (Atakan 2012 ).

Research and Development 52

Research and Development Medicine Access Media 52

StrainConnect

FEBRUARY 8, 2019

The difference between the cannabinoids CBD and THC. the magic line is drawn at the amount of THC content in the plant. THC, then it is considered hemp. THC, it is considered cannabis and is Federally deemed as a Schedule 1 drug. THC rule, if a Cannabis sativa L. THC, it is classified as cannabis.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed HB 324 , which establishes a regulatory commission to oversee the eventual “production, manufacturing, and dispensing” of products possessing specified quantities of plant-derived THC to qualified patients. Download the full 2019 Legislative Report. The law went into effect on July 1, 2019.

Legislation 59

Legislation Patients Access Banking 59